EU MDR Transition

The European Union (EU) Medical Devices Regulation (MDR) is a comprehensive regulatory framework that governs the safety, effectiveness, and quality of medical devices within the EU. It replaces the previous Medical Devices Directive (MDD) and aims to address the evolving challenges and advancements in the medical device industry.
Scope and Classification
The MDR expands the scope of medical devices to include certain products that were previously unregulated, such as certain aesthetic devices and devices for cleaning, disinfection, and sterilization. It also introduces more specific criteria for device classification, placing a greater emphasis on risk-based classification. This approach ensures that devices with higher risks undergo more stringent regulatory requirements.
Increased Requirements for Clinical Evidence
One of the significant changes introduced by the MDR is the increased emphasis on clinical evidence. Manufacturers are now required to provide comprehensive clinical data to demonstrate the safety and performance of their devices. This includes conducting clinical investigations for certain high-risk devices. The MDR also establishes stricter requirements for clinical evaluation and post-market clinical follow-up to ensure the continuous monitoring of device performance.
Strengthened Post-Market Surveillance
The MDR enhances post-market surveillance (PMS) activities to ensure the ongoing safety and performance of medical devices. Manufacturers must establish robust systems for collecting and analyzing real-world data on device performance and adverse events. Notified Bodies and competent authorities play a more active role in overseeing PMS, including conducting audits and inspections. This proactive approach enables early detection of potential safety issues and facilitates appropriate corrective actions.
Unique Device Identification (UDI) System
To enhance traceability and improve post-market surveillance, the MDR introduces a Unique Device Identification (UDI) system. Each medical device will be assigned a unique identifier, allowing for accurate tracking and retrieval of device-specific information. The UDI system enhances transparency, facilitates recall management, and enables healthcare professionals to access up-to-date information about the devices they use.
Strengthened Role of Notified Bodies
Notified Bodies play a crucial role in the MDR by assessing the conformity of medical devices. The MDR introduces stricter requirements for Notified Bodies, including enhanced competence assessment and increased scrutiny of their operations. The regulation also emphasizes the need for greater coordination and collaboration among notified bodies to ensure consistency in the assessment process. These changes aim to strengthen the reliability and accountability of notified bodies in the conformity assessment process.
Implications for Stakeholders
The MDR has significant implications for various stakeholders in the medical device industry. Manufacturers must invest additional resources and expertise to meet the increased regulatory requirements, including conducting more extensive clinical evaluations and generating robust clinical evidence. Notified Bodies face a greater workload due to the increased scrutiny and requirements for conformity assessments. Healthcare professionals will benefit from improved device safety and performance, as the MDR ensures that only high-quality and clinically validated devices are available on the market.
The EU Medical Devices Regulation (MDR) represents a significant step forward in enhancing the safety, effectiveness, and accountability of medical devices within the European Union. Through its comprehensive provisions, including expanded scope, increased requirements for clinical evidence, strengthened post-market surveillance, and the implementation of the UDI system, the MDR aims to provide patients and healthcare professionals with access to safe and reliable medical devices. While the MDR presents challenges for manufacturers and Notified Bodies, it ultimately serves the greater goal of protecting patients and improving the overall quality of healthcare.
We will help you ensure your medical devices remain compliant and able to be sold within the EU.
Please contact us today to discuss your requirements.
Call us to ensure your medical devices remain compliant
CE Marking
Quality Management System (QMS), Technical File and Risk Management Documentation for the CE Mark.
Read more
MDR Transition
We will help you ensure your medical devices remain compliant and able to be sold in the EU.
Read more
IVDR Transition
We will help you ensure your IVDs remain compliant and able to be sold within the EU.
Read more
ISO 27001:2022
SGB Consulting help you through the audit process to gain ISO 27001:2022 certification.
Read more
ISO 13485:2016
Allow us to professionally lead you through the audit process to a successful ISO 13485:2016 certification.
Read more
Software QA
We supply Software Quality Assurance and Regulatory Advice to ensure CE Mark or FDA approval.
Read more
Market Access
Helping your company gain access and compliance in all the main markets for medical devices globally.
Read more
Post Brexit Solutions
We support foreign device manufacturers to fully comply with the post-Brexit requirements.
Read more
EUDAMED
informed about the latest updates and requirements regarding EUDAMED to ensure compliance.
Read more
Other Services
As a one-stop-shop for our customers, our services cover everything required for continued compliance.
Read moreGlobal Market Access & Compliance
We can help you gain access to a wide range of global medical device markets including, but not limited to the following:






